Yifeng Pharmacy (603939) Semi-annual Report of 2019 Comment: Sustained High Performance, Plans to Use Convertible Bond Financing to Boost Expansion
Yifeng Pharmacy (603939) Semi-annual Report of 2019 Comment: Sustained High Performance, Plans to Use Convertible Bond Financing to Boost Expansion Event: The company released its 2019 interim report and public offering of convertible bonds.In the first half of 2019, it achieved operating income of 50.4.8 billion (+68.65%); net profit attributable to mother 3.08 thousand yuan … Read moreYifeng Pharmacy (603939) Semi-annual Report of 2019 Comment: Sustained High Performance, Plans to Use Convertible Bond Financing to Boost Expansion